PR

Poonam Rawat

Active Director Director DIN 10447437
DIN 10447437 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Poonam Rawat

Data last updated:

Poonam Rawat is a Director at Nayyam Pharma Private Limited (since 2023). Nayyam Pharma Private Limited reported revenue of ₹50,393 (FY 2025).

DIN 10447437
Primary Designation Director
First Appointment 30 Dec 2023
Oldest Company Age 2 yrs
Largest company Nayyam Pharma Private Limited · ₹50,393 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nayyam Pharma Private Limited U47721MP2023PTC069175
Director30 Dec 20232023₹50,393 (FY 2025)Active

Board colleagues of Poonam Rawat

NameDINCompanyDesignation
Ashish Verma10447436Nayyam Pharma Private LimitedDirector
Kalpana Mishra10447438Nayyam Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nayyam Pharma Private Limited
Premium access

Shareholding and investment profile for Poonam Rawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Rawat

Poonam Rawat currently holds 1 directorship: Nayyam Pharma Private Limited (Director, since 30 Dec 2023, revenue ₹50,393 (FY 2025)).

Poonam Rawat was first appointed on 30 Dec 2023 as Director at Nayyam Pharma Private Limited.

The current boards of Poonam Rawat's companies include Ashish Verma (Nayyam Pharma Private Limited), Kalpana Mishra (Nayyam Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available